Literature DB >> 21967611

Genetic modifiers of sickle cell disease.

Swee Lay Thein1.   

Abstract

Sickle cell disease is one of the best characterized human monogenic disorders. Complex genotype/phenotype correlations clearly demonstrate the interaction of multiple genetic and environmental factors. In the last 20 years, scientific research has applied genetic approaches to dissect some of these modifiers. This review highlights the more recent genetic association studies that have been applied to unravel the genetic modifiers of sickle cell disease including Hb F genetics, and the key genetic variants identified. Illumination of such modifying factors may guide future therapeutic interventions and improve prediction of disease severity, with implications for genetic counseling, prenatal diagnosis and implementation of high risk therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21967611     DOI: 10.3109/03630269.2011.615876

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  9 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

2.  The Hidden Complexity of Mendelian Traits across Natural Yeast Populations.

Authors:  Jing Hou; Anastasie Sigwalt; Téo Fournier; David Pflieger; Jackson Peter; Jacky de Montigny; Maitreya J Dunham; Joseph Schacherer
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

3.  Clinical Factors Associated with Morbidity and Mortality in Patients Admitted with Sickle Cell Disease.

Authors:  K Galloway-Blake; M Reid; C Walters; J Jaggon; M G Lee
Journal:  West Indian Med J       Date:  2015-03-05       Impact factor: 0.171

Review 4.  Genetic Network Complexity Shapes Background-Dependent Phenotypic Expression.

Authors:  Jing Hou; Jolanda van Leeuwen; Brenda J Andrews; Charles Boone
Journal:  Trends Genet       Date:  2018-06-11       Impact factor: 11.639

5.  The compound state: Hb S/beta-thalassemia.

Authors:  Maria Stella Figueiredo
Journal:  Rev Bras Hematol Hemoter       Date:  2015-03-14

6.  Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells.

Authors:  Kai-Hsin Chang; Sarah E Smith; Timothy Sullivan; Kai Chen; Qianhe Zhou; Jason A West; Mei Liu; Yingchun Liu; Benjamin F Vieira; Chao Sun; Vu P Hong; Mingxuan Zhang; Xiao Yang; Andreas Reik; Fyodor D Urnov; Edward J Rebar; Michael C Holmes; Olivier Danos; Haiyan Jiang; Siyuan Tan
Journal:  Mol Ther Methods Clin Dev       Date:  2017-01-11       Impact factor: 6.698

7.  The Effect of Alpha Thalassemia, HbF and HbC on Haematological Parameters of Sickle Cell Disease Patients in Ibadan, Nigeria.

Authors:  Foluke Atinuke Fasola; Oluwatoyin Aduke Babalola; Biobele Jotham Brown; Abayomi Odetunde; Adeyinka Gladys Falusi; Olufunmilayo Olopade
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

8.  Whole blood transcriptomic analysis reveals PLSCR4 as a potential marker for vaso-occlusive crises in sickle cell disease.

Authors:  Hawra Abdulwahab; Muna Aljishi; Ameera Sultan; Ghada Al-Kafaji; Kannan Sridharan; Moiz Bakhiet; Safa Taha
Journal:  Sci Rep       Date:  2021-11-12       Impact factor: 4.379

9.  Genomic architecture of sickle cell disease in West African children.

Authors:  Jacklyn Quinlan; Youssef Idaghdour; Jean-Philippe Goulet; Elias Gbeha; Thibault de Malliard; Vanessa Bruat; Jean-Christophe Grenier; Selma Gomez; Ambaliou Sanni; Mohamed C Rahimy; Philip Awadalla
Journal:  Front Genet       Date:  2014-02-14       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.